| Brianna Davis, LCSW | |
|
45 E Vine St, Murray, UT 84107-7904 | |
| (801) 226-4643 | |
| Not Available |
| Full Name | Brianna Davis |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 45 E Vine St, Murray, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053992206 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 8294087-3501 (Utah) | Primary |
| Entity Name | Utah Healing Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033558697 PECOS PAC ID: 8325351414 Enrollment ID: O20150717002678 |
News Archive
A new research technique, pioneered by Dr. Maria Angela Franceschini, will be published in JoVE (Journal of Visualized Experiments) on March 14th. Researchers at Massachusetts General Hospital and Harvard Medical School have developed a non-invasive optical measurement system to monitor neonatal brain activity via cerebral metabolism and blood flow.
According to the latest research hormone replacement therapy (HRT) may not be quite as dangerous as was first implied by a major American study in 2002.
Quality Systems, Inc. announced today that its chairman of the board and founder, Sheldon Razin, was named the winner in the software category of TechAmerica's 52nd annual Innovator Awards, which honors eight innovators representing different industry segments for their contributions to the technology industry.
Most of the current clinical anti-tumor drugs used in chemotherapy move around in the patient's blood after intake and are unable to pinpoint the targeted tumor. As a result, while killing the tumor cells, the healthy cells may also be killed as "collateral damage", leading to undesired side effects.
Albireo today announced positive top-line results from a Phase IIb study in chronic idiopathic constipation (CIC) assessing efficacy and safety of three different dose levels (5, 10 and 15 mg orally once a day) of the investigational drug A3309 during an eight week trial. Analyses of the data show clinically meaningful and statistically significant improvement for patients treated with A3309 compared to placebo-treated patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brianna Davis, LCSW 108 W 520 N, Vineyard, UT 84059-2702 Ph: (801) 362-8737 | Brianna Davis, LCSW 45 E Vine St, Murray, UT 84107-7904 Ph: (801) 226-4643 |
News Archive
A new research technique, pioneered by Dr. Maria Angela Franceschini, will be published in JoVE (Journal of Visualized Experiments) on March 14th. Researchers at Massachusetts General Hospital and Harvard Medical School have developed a non-invasive optical measurement system to monitor neonatal brain activity via cerebral metabolism and blood flow.
According to the latest research hormone replacement therapy (HRT) may not be quite as dangerous as was first implied by a major American study in 2002.
Quality Systems, Inc. announced today that its chairman of the board and founder, Sheldon Razin, was named the winner in the software category of TechAmerica's 52nd annual Innovator Awards, which honors eight innovators representing different industry segments for their contributions to the technology industry.
Most of the current clinical anti-tumor drugs used in chemotherapy move around in the patient's blood after intake and are unable to pinpoint the targeted tumor. As a result, while killing the tumor cells, the healthy cells may also be killed as "collateral damage", leading to undesired side effects.
Albireo today announced positive top-line results from a Phase IIb study in chronic idiopathic constipation (CIC) assessing efficacy and safety of three different dose levels (5, 10 and 15 mg orally once a day) of the investigational drug A3309 during an eight week trial. Analyses of the data show clinically meaningful and statistically significant improvement for patients treated with A3309 compared to placebo-treated patients.
› Verified 1 days ago
Mr. James Matthew Upton, LCSW, BCBA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4444 S 700 E Ste 203, Murray, UT 84107 Phone: 801-268-4887 | |
Shane D Adamson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 525 E 4500 S, F-200, Murray, UT 84107 Phone: 801-747-2300 | |
Nancy M Hogarty Baker, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5250 So Commerce Dr, Ste 250, Murray, UT 84107 Phone: 801-261-3500 Fax: 801-261-2111 | |
Sevon Taroian, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 154 E Myrtle Ave Ste 204, Murray, UT 84107 Phone: 801-369-8989 Fax: 801-704-9741 | |
Malisa May Lemon, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 5284 S Commerce Dr Ste C134, Murray, UT 84107 Phone: 801-266-4643 | |
Sloane Rampton, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4848 S Commerce Dr, Murray, UT 84107 Phone: 385-232-3484 | |
Mary Elizabeth Andolsek, LCSW,CT Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5411 S Vine St # 6, Murray, UT 84107 Phone: 801-783-8401 |